School of Medicine


Showing 41-60 of 61 Results

  • David A. Relman

    David A. Relman

    Thomas C. and Joan M. Merigan Professor and Professor of Microbiology and Immunology

    Current Research and Scholarly InterestsMy investigative program focuses on human-microbe interactions and human microbial ecology, and primarily concerns the ecology of human indigenous microbial communities; a secondary interest concerns the classification of humans with systemic infectious diseases, based on features of genome-wide gene transcript abundance patterns and pther aspects of the host response.

  • Cybele A. Renault, MD, DTM&H, FIDSA

    Cybele A. Renault, MD, DTM&H, FIDSA

    Clinical Associate Professor, Medicine - Infectious Diseases

    BioDr. Renault has devoted her career to caring for vulnerable patient populations, both domestically and overseas. She completed her medical school and residency training at the University of Chicago, caring for underserved patients on Chicago's South Side, followed by a Chief Resident year at John H. Stroger, Jr. Hospital of Cook County, the public hospital serving the uninsured in Chicago. She began her career in global health as an Infectious Diseases fellow at Stanford, validating low-cost HIV diagnostics in Burkina Faso, and providing clinical service and teaching in India and Zimbabwe as a fellow, and later in Thailand, Uganda, Rwanda and Kenya as one of our Infectious Diseases faculty. Her clinical work is currently focused on caring for our Veteran population, working to empower Veterans to engage in their care, often in the setting of significant mental illness.

    Dr. Renault is most passionate about medical education and program development to combat global antimicrobial resistance through antimicrobial stewardship, to create opportunities for the Internal Medicine residents centering on caring for vulnerable patient populations, and to develop impactful and sustainable programs in collaboration with our low- and middle-income partners for our Center for Innovation in Global Health. She served as Associate Program Director for the Internal Medicine Residency Program for 4 years prior to transitioning to her current role as Program Lead for Global Health, for which she leads the Global Health Track for the Internal Medicine residency program and develops global health initiatives for the Department of Medicine. She co-founded and has been director of the Stanford 2-week intensive global health course since its inception in 2012, she has structured trainee and faculty rotations based on evolving needs of our partner sites in Uganda, Rwanda and Zimbabwe, she is the faculty lead for the ID/antimicrobial stewardship partnership between Stanford and Moi Teaching and Referral Hospital in Eldoret, Kenya, and she is leading Stanford's multi-disciplinary efforts to support our newest partner in Negele Arsi, Ethiopia.

    Dr. Renault strives to augment Stanford's contributions and support for underserved patient populations in the United States. She established resident rotations in Shiprock, New Mexico and Chinle, Arizona through the Indian Health Service, and she is Faculty Advisor for the Internal Medicine Health Equity, Advocacy and Research concentration in the residency program. She also aspires to improve resources for women physicians. In 2016, Dr. Renault established the GME Women in Medicine Leadership Council, with the intention of creating community and encouraging conversations about professional and personal life decisions as women in the field of medicine. She is passionate about mentoring through sharing personal experiences, creating an environment that encourages reflection, and building skills to address challenges unique to women in medicine.

    In 2022, in recognition of her passion for medical education and her success in program development, Dr. Renault was asked to join the leadership at Palo Alto Veterans Health Care System as Deputy Associate Chief of Staff for Education. In this role, she works with rotation directors to optimize their respective rotations to offer robust educational opportunities for trainees across specialties who are rotating at the Palo Alto VA.

  • Arjun Rustagi, MD, PhD

    Arjun Rustagi, MD, PhD

    Instructor, Medicine - Infectious Diseases

    BioDr. Arjun Rustagi is an Instructor in Medicine. He is a graduate of the University of Washington Medical Scientist Training Program and Stanford's Internal Medicine Residency and Infectious Diseases Fellowship.
    He is dedicated to understanding the early immune responses to infections, and the methods pathogens use to persist despite these responses, in order to inform new prevention and treatment strategies. He studies viral pathogenesis and immunity with Dr. Catherine Blish, under whose mentorship he set up the respiratory viral biosafety level 3 (BSL3) program at Stanford in early 2020 in order to study SARS-CoV-2, contributing to several projects in SARS-CoV-2 virology including a study of intact in vitro lung tissue infection. He also protocoled the first peripheral immune profiling study of severe COVID-19. His ongoing interest is in the full spectrum of in vitro respiratory viral models, particularly those that recapitulate lung epithelium and mucosal immunity.

  • Gary Schoolnik

    Gary Schoolnik

    Professor of Medicine (Infectious Diseases), Emeritus

    Current Research and Scholarly InterestsStructure-function analysis of bacterial adhesion proteins and toxins; design and synthesis of synthetic antigens; immunobiology of human papillomaviruses

  • Jake Scott

    Jake Scott

    Clinical Assistant Professor, Medicine - Infectious Diseases

    BioDr. Jake Scott is a board-certified infectious diseases specialist. He provides general infectious diseases care in the inpatient and outpatient settings and his special interests include COVID-19, coccidiomycosis, multidrug-resistant organisms, HIV, and HIV pre-exposure prophylaxis. He works with patients from diverse backgrounds to provide compassionate, high-quality care aligned with their needs.

    Dr. Scott was born and raised in the Bay Area and was inspired to pursue a career in medicine after working as an HIV test counselor in San Francisco. He studied literature and creative writing in college and values the narrative aspect of medicine and the importance of drawing out the story behind the diagnosis.

    One of Dr. Scott’s passions is teaching. He regularly works with Stanford residents and students and has lectured on various infectious disease-related topics, such as COVID-19, fever of unknown origin, and the dangers of antibiotic overuse, especially as it contributes to the rising threat of multidrug-resistant infections. He is also committed to expanding awareness of infectious diseases outside of the hospital and university through public presentations in the community and media interviews.
    He is the medical director of the Antimicrobial Stewardship Program at Stanford Health Care – ValleyCare in Pleasanton and is a member of the Infection Control Committee and the Stanford Vaccine Clinical Advisory Committee.

    In his spare time, Dr. Scott enjoys rock climbing, hiking, and spending time with his wife and two young children.

  • Robert W. Shafer

    Robert W. Shafer

    Professor (Research) of Medicine (Infectious Diseases) and, by courtesy, of Pathology

    Current Research and Scholarly InterestsMy group’s research is on the mechanisms and consequences of virus evolution with a focus on HIV therapy and drug resistance. We maintain a public HIV drug resistance database (http://hivdb.stanford.edu) as a resource for HIV drug resistance surveillance, interpreting HIV drug resistance tests, and HIV drug development. Our paramount goal is to inform HIV treatment and prevention policies by identifying the main factors responsible for the emergence and spread of drug resistance.

  • Upinder Singh

    Upinder Singh

    Stanford Medicine Professor of Infectious Disease and Professor of Medicine (Infectious Diseases & Geographic Medicine) and of Microbiology and Immunology

    Current Research and Scholarly InterestsOur lab elucidates the molecular basis of pathogenesis of the protozoan parasite Entamoeba histolytica. We use genetic and genomic approaches to identify novel virulence determinants and to characterize the global epidemiology of the parasite.

  • David A. Stevens

    David A. Stevens

    Professor of Medicine, Emeritus

    Current Research and Scholarly InterestsImmunology and chemotherapy of human fungal diseases, particularly coccidioidomycosis (Valley Fever) in California and aspergillosis, and the parasitic disease, trypanosomiasis.

  • Ashley Styczynski

    Ashley Styczynski

    Adjunct Clinical Assistant Professor, Medicine - Infectious Diseases

    BioAshley Styczynski, MD, MPH, is an Adjunct Clinical Assistant Professor in the Division of Infectious Diseases & Geographic Medicine and Global Health Faculty Fellow, and a Medical Officer in the International Infection and Control Program at the Centers for Disease Control and Prevention (CDC). Dr. Styczynski's research interests are in infectious disease epidemiology, global health, emerging infections, and antimicrobial resistance. She holds an MPH from Johns Hopkins Bloomberg School of Public Health and an MD from University of Illinois at Chicago. Prior to coming to Stanford for her infectious disease fellowship, she spent two years as an Epidemic Intelligence Service (EIS) Officer at the CDC. During her time as an EIS officer, Dr. Styczynski conducted outbreak investigations on Zika virus, vaccinia virus, and rabies. She is currently conducting research on antimicrobial resistance and interventions to reduce nosocomial infections within low-resource healthcare facilities.

  • Aruna Subramanian

    Aruna Subramanian

    Clinical Professor, Medicine - Infectious Diseases

    Current Research and Scholarly InterestsMy research and scholarly interests have focused on tailoring antimicrobial prophylaxis in specific highly immunocompromised hosts depending on their specific infectious disease risks. I am interested in developing diagnostic algorithms and treatment protocols that will improve the quality of care in transplant and oncology patients.

    I also have an interest in training ID fellows in this very specialized area of patient care. To that end, we have started a new ICHS ID fellowship with a specialized curriculum and are developing supplemental educational materials to enhance this training, which can be implemented at other academic training centers.

  • Lucy Tompkins

    Lucy Tompkins

    Lucy Becker Professor of Medicine and Professor, by courtesy, of Microbiology and Immunology

    Current Research and Scholarly InterestsGenetic and cellular basis of pathogenicity of Helicobacter pylori. Molecular epidemiology, hospital epidemiology, quality improvement in healthcare associated infections.

  • Elena Vendrame

    Elena Vendrame

    Adjunct Clinical Assistant Professor, Medicine - Infectious Diseases

    Current Research and Scholarly InterestsMy research focuses on understanding the host-pathogen interactions. In particular I study the interaction between natural killer cells and HIV.

  • Taia T. Wang, MD, PhD, MSCI

    Taia T. Wang, MD, PhD, MSCI

    Assistant Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology

    Current Research and Scholarly InterestsLaboratory of Mechanisms in Human Immunity and Disease Pathogenesis

    Antibodies are a critical component of host defense. While the importance of humoral immunity has been recognized for decades, substantial gaps in knowledge remain around how antibodies function, and how their function is regulated, in vivo. Our laboratory performs studies designed to fill in these gaps, with the goal of enabling new vaccine and therapeutic strategies to prevent human disease. My interest in this area culminated from training in medicine, RNA virus biology (PhD), and molecular antibody biology (postdoctoral training). The intersection of these topics, viral immunity and disease pathogenesis, is the focus of our work. The essential question driving our research is why a small subset of people develop severe or fatal disease during viral infection while most infections result in a subclinical or mild outcome, even in at-risk populations. Our hypothesis is that the antibody signaling pathways that are engaged during viral infection through Fc gamma receptors (FcγRs) are a key driver of these distinct outcomes. We are focused on several major unknowns to address this hypothesis: How are antibody effector functions regulated in vivo and does this change in disease? How do distinct signaling pathways engaged by IgG immune complex-FcγR interactions impact host cell genetic regulation and the ultimate inflammatory/immune response? What are the tissue-specific functions that antibodies engage? How does the heterogeneity in post-translational modifications (PTMs) of human antibodies contribute to heterogeneity in viral immunity?



    Current clinical studies:
    Recruiting:

    An Open Label Study of IgG Fc Glycan Composition in Human Immunity
    Principal Investigator: Taia T. Wang, MD, PhD
    ClinicalTrials.gov Identifier:
    NCT01967238